Bacterin International (BONE) takes a hit in the post session after posting a wider Q4 loss and...

|By:, SA News Editor

Bacterin International (BONE) takes a hit in the post session after posting a wider Q4 loss and missing consensus estimates. Revenue actually jumped 72% Y/Y, but its bottom line was negatively impacted by increased discounting on stocking purchase orders and non recurring adjustments. Shares -11% AH.